# WORK Medical subsidiary Neologics signs $114,000 service contract with GemPharmatech

Neologics Bioscience Inc., a subsidiary of WORK Medical Technology Group, has entered into a service agreement with GemPharmatech Corporation to provide testing services for $114,000. The services include material preparation, serum titer analysis, hybridoma fusion, antibody sequencing, and in vitro validation.

- Type: Contract
- Announced: 2025-11-04
- Where: San Diego, California, United States
- Value: $114K
- Status: announced
- Products: testing services for recombinant antibodies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [WORK Medical Technology Group](https://endata.com/companies/88249.md)
- [Neologics Bioscience Inc.](https://endata.com/companies/88250.md)
- [GemPharmatech Corporation](https://endata.com/companies/88251.md) (customer)

## Sources

- [globenewswire.com](https://www.globenewswire.com/fr/news-release/2025/11/04/3180422/0/en/work-medical-technology-group-ltd-s-subsidiary-retains-a-us-114-000-service-contract-from-gempharmatech-corporation.html), 2025-11-04: "Neologics has entered into a key service agreement with GemPharmatech Corporation to provide specified testing services for GemPharmatech."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.